North America Fluoroscopy Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 2.21 Billion |
| Market Size (2029) | USD 2.78 Billion |
| CAGR (2024 - 2029) | 4.68 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Fluoroscopy Market Analysis
The North America Fluoroscopy Devices Market size is estimated at USD 2.21 billion in 2024, and is expected to reach USD 2.78 billion by 2029, growing at a CAGR of 4.68% during the forecast period (2024-2029).
The major factors driving the growth of the market in North America are the presence of established healthcare infrastructure, technological advancements, rising demand for minimally-invasive surgeries, growing geriatric population and prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
As per the January 2024 update by the Population Reference Bureau, by 2050, the United States is set to witness a significant demographic shift; the population of individuals aged 65 and above is expected to surge from 58 million in 2022 to 82 million, marking a 47% increase. Moreover, the proportion of this age group within the overall population is anticipated to climb from 17% to 23%. The elderly population is more prone to chronic conditions such as cardiovascular, neurological disorders, and other diseases, which is expected to have a positive impact on the market.
Fluoroscopes are commonly used in procedures such as cardiac catheterization, arthrography (for joint visualization), lumbar punctures, and the placement of intravenous (IV) catheters. Thus, the increase in cardiovascular complications in North America is expected to drive market demand over the forecast period. As per the July 2022 update by Heart Disease in Canada, men were two times more likely to suffer a heart attack than women in Canada. Hence, the high prevalence and chance of heart attack cases is likely to favor the utilization of fluoroscopes in the country, leading to market growth over the forecast period.
Owing to the above-mentioned factors, the market is expected to grow significantly over the forecast period. However, the side effects associated with radiation are expected to hinder market growth over the forecast period.
North America Fluoroscopy Market Trends
The Cardiovascular Segment is Expected to Hold Significant Market Share by Application over the Forecast Period
The rising burden of cardiovascular diseases in North America is a major factor driving the growth of the market. For instance, as per the data from the Centers for Disease Control and Prevention published in October 2022, 805,000 people in the United States had a heart attack annually; 605,000 of these comprised a first-time heart attack, while 200,000 were caused by previous heart attacks. As stated by the American Heart Association 2021 journal, it is estimated that by 2035, more than 130 million adults in the United States will have some type of heart disease.
The statistics provided by the Heart and Stroke Foundation of Canada in February 2022 showed that there were 750,000 people with heart failure, and 100,000 people were diagnosed with this condition annually. As per the data from the American Heart Association 2022, in Mexico, 56.1% of adults had high levels of LDL-C, or bad cholesterol, which is thought to be the primary risk factor for cardiovascular disease. Cardiovascular diseases, such as high blood pressure, arrhythmias, and strokes are increasing the demand for fluoroscopy devices. This, along with the growing demand for minimally invasive surgeries and technological advancements, is expected to drive market growth in the near future.
Initiatives by key market players are expected to increase market growth. For instance, in August 2022, Xoran Technologies received FDA 510(k) clearance for TRON, a mobile, full-body fluoroscopy, computed tomography (CT) X-ray system. Additionally, in July 2022, Fujifilm launched a 2-in-1 fluoroscopy digital radiography system. The platform features an innovative, pivoting tube head and removable detector design to enable greater freedom of imaging and efficiency compared to conventional configurations of a separate c-arm and mobile X-ray machine. Such advanced product launches will facilitate the increasing need for various cardiovascular disease diagnoses, leading to segmental growth over the forecast period.
Thus, the increase in the incidence of cardiovascular diseases and rising initiatives by key market players are expected to boost segmental growth.
The United States is Expected to Hold a Significant Market Share Over the Forecast Period
The United States is expected to hold a significant market share due to increasing incidences of trauma and injuries and rising initiatives by market players. The incidence of sport-related injuries, such as ligament sprains, muscle sprains, supraspinatus tendinitis, and others, is increasing among the population. This is anticipated to fuel the demand for medical imaging, boosting market growth. For instance, the National Safety Council (NSC) reported that in 2022, exercise equipment alone led to an estimated 445,642 injuries, surpassing all other sports and recreation categories.
As per the Sports Accident Statistics report updated by LegalMatch in August 2022, injuries to the anterior cruciate ligament (ACL) occurred roughly 150,000 times in the United States annually. In addition, female basketball and soccer players had an ACL injury 2 to 8 times more frequently than other athletes. This prevalence of a high number of sports-related injuries in the region is expected to boost the demand for medical imaging in the country.
Initiatives by key market players, such as partnership agreements, are another factor driving market growth. For instance, in March 2022, OXOS Medical entered into distribution partnerships with Pacific Medical, Redstone Ortho, and Specialty Medical. These partnerships allow OXOS to bring advanced orthopedic imaging to the entire country. Pacific Medical, Redstone Ortho, and Specialty Medical added unprecedented scale to Micro C's commercialization, giving providers in their geographies an opportunity to see how OXOS can assist in delivering the most efficient, highest-quality orthopedic care in both their surgical and clinical settings. Thus, such agreements are expected to boost market growth in the country over the forecast period.
North America Fluoroscopy Industry Overview
The North American fluoroscopy devices market is consolidated and competitive. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the players who are currently dominating the market are GE Healthcare (GE Company), Carestream Health, Canon Medical Systems Corporation, Siemens Healthineers, Koninklijke Philips NV, Hologic Inc., Orthoscan Inc., and Shimadzu Medical.
North America Fluoroscopy Market Leaders
-
GE Healthcare (GE Company)
-
Carestream Health
-
Canon Medical Systems Corporation
-
Siemens Healthineers
-
Koninklijke Philips NV
*Disclaimer: Major Players sorted in no particular order
North America Fluoroscopy Market News
- December 2023: The Walter Reed Team developed an online fluoroscopy course for enhanced patient and staff safety. The two-hour course comprises five modules, including understanding risks, fluoroscopy operating modes, fluoroscopy optimization technique, radiation dose parameters, and skin effects and methods for exposure reduction.
- July 2023: The Laurie K. Lacob Pavilion, dedicated to transplant and cellular therapies, was launched at the Stanford Medicine Cancer Center. The facility will boast 232 private patient beds, 21 cutting-edge operating rooms, 72 recovery bays, and upgraded fixed fluoroscopy and diagnostic imaging units once fully opened, which is expected to occur by 2030.
North America Fluoroscopy Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally-invasive Surgeries
4.2.2 Growing Geriatric Population and Prevalence of Chronic Diseases
4.2.3 Increasing Use of Fluoroscopy in Pain Management
4.3 Market Restraints
4.3.1 Side Effects and Radiation Exposure
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Device Type
5.1.1 Fixed Fluoroscopes
5.1.2 Mobile Fluoroscopes
5.1.2.1 Full-size Fluoroscopes
5.1.2.2 Mini Fluoroscopes
5.2 By Application
5.2.1 Orthopedic
5.2.2 Cardiovascular
5.2.3 Pain Management and Trauma
5.2.4 Neurology
5.2.5 Gastrointestinal
5.2.6 Urology
5.2.7 General Surgery
5.2.8 Other Applications
5.3 Geography
5.3.1 United States
5.3.2 Canada
5.3.3 Mexico
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health
6.1.3 GE Healthcare
6.1.4 Hologic Inc.
6.1.5 Koninklijke Philips NV
6.1.6 Orthoscan Inc.
6.1.7 Shimadzu Medical
6.1.8 Siemens Healthineers
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
North America Fluoroscopy Industry Segmentation
As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, fluoroscopy produces live, moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. A typical fluoroscope has four components, which include an X-ray source, an X-ray image intensifier, an imaging system, and a workstation.
The North American fluoroscopy devices market is segmented by device type, application, and geography. By device type, the market is segmented into fixed and mobile fluoroscopes. By mobile fluoroscopes, the market is segmented into full-sized fluoroscopes and mini fluoroscopes. By application, the market is segmented into orthopedic, cardiovascular, pain management and trauma, neurology, gastrointestinal, urology, general surgery, and other applications. By geography, the market is segmented into the United States, Canada, and Mexico. The report offers the values (USD) for all the above segments.
| By Device Type | ||||
| Fixed Fluoroscopes | ||||
|
| By Application | |
| Orthopedic | |
| Cardiovascular | |
| Pain Management and Trauma | |
| Neurology | |
| Gastrointestinal | |
| Urology | |
| General Surgery | |
| Other Applications |
| Geography | |
| United States | |
| Canada | |
| Mexico |
North America Fluoroscopy Market Research FAQs
How big is the North America Fluoroscopy Market?
The North America Fluoroscopy Market size is expected to reach USD 2.21 billion in 2024 and grow at a CAGR of 4.68% to reach USD 2.78 billion by 2029.
What is the current North America Fluoroscopy Market size?
In 2024, the North America Fluoroscopy Market size is expected to reach USD 2.21 billion.
Who are the key players in North America Fluoroscopy Market?
GE Healthcare (GE Company), Carestream Health, Canon Medical Systems Corporation, Siemens Healthineers and Koninklijke Philips NV are the major companies operating in the North America Fluoroscopy Market.
What years does this North America Fluoroscopy Market cover, and what was the market size in 2023?
In 2023, the North America Fluoroscopy Market size was estimated at USD 2.11 billion. The report covers the North America Fluoroscopy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Fluoroscopy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Fluoroscopy Industry Report
Statistics for the 2024 North America Fluoroscopy Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Fluoroscopy Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
